Summary: Cigna Healthcare modified its laboratory testing services coverage policy (MM 0604), effective May 16, 2026. Here's what billing teams need to know before claims start hitting your denial queue.
Cigna Healthcare — the full official name of the payer — updated coverage position criteria for laboratory testing services under policy MM 0604. The published source document does not list specific CPT or HCPCS codes in the version captured by PayerPolicy. That alone should put your revenue cycle team on alert. Lab billing is already one of the highest-denial categories across commercial payers, and a modified coverage policy with shifting medical necessity criteria means your charge capture and authorization workflows need a hard look before May 16, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Laboratory Testing Services (MM 0604) |
| Policy Code | MM 0604 |
| Change Type | Modified |
| Effective Date | May 16, 2026 |
| Impact Level | High |
| Specialties Affected | Clinical laboratory, pathology, primary care, oncology, internal medicine, any specialty ordering lab services billed to Cigna |
| Key Action | Pull the full MM 0604 policy document, compare it against your current charge capture and prior authorization workflows, and audit any pending lab claims before May 16, 2026 |
Cigna Laboratory Testing Services Coverage Criteria and Medical Necessity Requirements 2026
The real issue with any modification to a Cigna laboratory testing coverage policy is scope. Lab testing spans thousands of CPT codes — from routine chemistry panels to molecular diagnostics — and a single policy update can quietly shift what Cigna considers medically necessary across dozens of specialties.
The published MM 0604 document captures Cigna's coverage position criteria for laboratory testing services. Because the version indexed by PayerPolicy does not include granular indication-level detail or a specific code list in this capture, the exact nature of the modification — whether Cigna tightened medical necessity criteria, added exclusions, shifted prior authorization requirements, or updated clinical guidelines — is not confirmed from the source data alone. Do not assume the change is minor. Policy modifications to broad lab testing policies at commercial payers consistently carry high financial exposure.
What is confirmed: the effective date is May 16, 2026. That is your hard deadline for reviewing how MM 0604 affects your current billing guidelines and authorization processes. If you order or bill lab services to Cigna members and haven't pulled the full policy document from Cigna's coverage policy portal, do that today.
Medical necessity is the central variable in lab claim denials under commercial payers. Cigna, like other major commercial payers, requires that lab tests be ordered for a clear clinical indication — not as part of routine screening unless a specific screening benefit applies. A modification to MM 0604 could mean Cigna has changed which clinical scenarios it considers sufficient to establish medical necessity for specific test categories. That directly affects how your ordering providers document the clinical indication, and how your billing team attaches diagnosis codes to claims.
Prior authorization is the second lever. Some lab services under Cigna require prior authorization, particularly for high-cost molecular tests, genetic panels, and specialty assays. If MM 0604's modification changes which tests fall under prior authorization requirements, and your team doesn't catch it before May 16, 2026, you'll see a wave of denials that are difficult and time-consuming to appeal.
Cigna Laboratory Testing Services Exclusions and Non-Covered Indications
The source data for this policy capture does not include a specific list of excluded or non-covered indications. That is not the same as saying no exclusions exist.
Cigna's laboratory coverage policies routinely exclude tests that lack sufficient clinical evidence, tests ordered outside of approved clinical guidelines, duplicate testing within defined timeframes, and tests ordered for screening purposes in patients who don't meet the specified risk criteria. Experimental or investigational designation is a common reason for non-coverage on advanced molecular diagnostics and newer genomic assays.
Pull the full MM 0604 document directly from Cigna's coverage policy portal to confirm current exclusions. If your lab or practice orders any testing in the molecular diagnostics, pharmacogenomics, or genetic testing categories, treat those as high-risk until you've confirmed their status under the updated policy. These test categories are the most frequent targets for coverage restriction at commercial payers, and the reimbursement exposure per claim is significant.
If you're not sure how the updated exclusion language applies to your specific test mix, loop in your compliance officer before the May 16, 2026 effective date.
Coverage Indications at a Glance
The indexed version of MM 0604 does not include a structured, indication-level breakdown that can be reproduced here with confidence. The table below reflects the general framework of Cigna laboratory coverage policy based on the policy category. Verify every row against the actual MM 0604 document before using it in your billing workflows.
| Indication Category | Status | Notes |
|---|---|---|
| Routine clinical laboratory testing with documented medical necessity | Generally Covered | Diagnosis code must support clinical indication |
| Preventive/screening lab panels with qualifying benefit | Covered when benefit applies | Confirm member's plan includes screening benefit |
| Advanced molecular diagnostics / genetic testing | Coverage varies | High prior authorization risk; confirm under MM 0604 |
| Duplicate testing within payer-defined timeframe | Not Covered | Check frequency limits in full policy document |
| Investigational or experimental laboratory tests | Not Covered | Cigna applies evidence-based coverage standards |
| Tests ordered outside clinical guideline criteria | Not Covered | Medical necessity documentation must align with Cigna's criteria |
Cigna Laboratory Testing Billing Guidelines and Action Items 2026
Lab billing under a modified Cigna coverage policy requires immediate, specific action. Don't wait until you see the first denial. Here's what to do before May 16, 2026.
| # | Action Item |
|---|---|
| 1 | Pull the full MM 0604 policy document from Cigna's coverage policy portal now. The PayerPolicy source link points directly to the Cigna coverage position criteria document. Read it against your current charge capture processes and identify any criteria that differ from the previous version. Line-by-line comparison is the only way to know what actually changed. |
| 2 | Run a prior authorization audit for your top 20 lab codes billed to Cigna. If the MM 0604 modification added or changed prior authorization requirements for any test category, your team needs to know before claims drop. Pull your Cigna lab claims from the past 90 days, identify the most frequently billed test codes, and confirm each one's prior auth status under the updated policy. |
| 3 | Review your medical necessity documentation templates. If Cigna tightened criteria for any test categories, the clinical indication documented by the ordering provider must match. Work with your medical director or ordering physicians to update order templates and clinical documentation prompts before the effective date. |
| 4 | Audit Cigna lab claims currently in your AR for denial risk. Claims billed before May 16, 2026 fall under the prior policy version. But if you have claims in hold status or under review, confirm which policy version applies. Claims adjudicated after the effective date may be reviewed under the new criteria even if ordered earlier — verify Cigna's adjudication date policy. |
| 5 | Update your denial management workflow to flag MM 0604 as a watch category. After May 16, 2026, tag any Cigna lab denial that references coverage position criteria or medical necessity. Track the denial reason codes. If you see a spike tied to specific test categories, that's your signal to escalate and confirm whether your documentation process is aligned with the updated policy. |
| 6 | Contact your Cigna provider relations representative. Ask specifically whether the MM 0604 modification changes prior authorization requirements, medical necessity criteria, or adds new exclusions. Get that answer in writing. It's useful documentation if you need to appeal a denial. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Laboratory Testing Services Under MM 0604
The indexed version of the Cigna MM 0604 policy captured by PayerPolicy does not include a specific list of CPT, HCPCS, or ICD-10 codes. This is confirmed from the source data — no codes are listed in this policy capture.
This is a significant gap for laboratory testing billing. Lab claims live and die by code-level specificity, and a coverage policy modification without a published code list requires extra due diligence.
Here's what you need to do on the code front:
Pull the complete code list from the Cigna policy document directly. Coverage position criteria documents often include attached code lists or reference tables that aren't always captured in policy aggregator snapshots. Go to the source: the Cigna coverage policy portal linked in the MM 0604 entry.
Cross-reference your current lab CPT codes against Cigna's general laboratory fee schedule. Even without a specific code list in this capture, you can validate reimbursement status and coverage flags for your top codes through Cigna's provider portal.
Do not assume a code is covered because it was covered under the prior policy version. Modifications to coverage position criteria documents can add new exclusions, change frequency limits, or shift codes from covered to prior-authorization-required status without explicitly removing them from a covered list.
If Cigna publishes an updated code addendum alongside MM 0604 after May 16, 2026, PayerPolicy will capture that update. Set an alert for this policy in your PayerPolicy dashboard to catch any follow-on changes.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.